Article info
Viewpoint
Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?
- Correspondence to Professor Ulf Müller-Ladner, Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Clinic, Benekestrasse 2, Bad Nauheim 61231, Germany; u.mueller-ladner{at}kerckhoff-klinik.de
Citation
Ten years EULAR Scleroderma Research and Trials (EUSTAR): what has been achieved?
Publication history
- Received May 23, 2013
- Revised July 27, 2013
- Accepted September 8, 2013
- First published October 11, 2013.
Online issue publication
December 30, 2013
Article Versions
- Previous version (11 October 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions